Search for LIMS content across all our Wiki Knowledge Bases.
Type a search term to find related articles by LIMS subject matter experts gathered from the most trusted and dynamic collaboration tools in the laboratory informatics industry.
An organ chamber, organ bath, or isolated tissue bath, is a chamber in which isolated organs or tissues can be administered with drugs, or stimulated electrically, in order to measure their function. The tissue in the organ bath is typically oxygenated with carbogen and kept in a solution such as Tyrode's solution or lactated Ringer's solution.[citation needed] Historically, they have also been called gut baths.[1]
For studying the effects of drugs on receptors in drug discovery and combinatorial chemistry, novel techniques such as high throughput screening, ultrahigh throughput screening and high content screening, pharmacogenomics,
proteomics, and array technology have largely superseded the use of organ baths.[9] These techniques can allow more receptor specificity than organ bath preparations, as a single tissue sample can express many different receptor types.[citation needed]
The use of organ bath preparations for the measurement of physiological tissue responses to drug concentrations allows the generation of dose response curves. This in turn allows the quantification of a drug's pharmacological profile in the tissue in question, such as the calculation of the drug's EC50, IC50, and Hill coefficient.[citation needed]
Historical contributions
Examples of important contributions made using this technique include:
Nitric oxide using both assays of bull retractor penis and aortic ring.[12]
References
^Handley, Sheila L.; Singh, Lakhbir (January 1986). "Neurotransmitters and shaking behaviour — more than a 'gut-bath' for the brain?". Trends in Pharmacological Sciences. 7: 324–328. doi:10.1016/0165-6147(86)90371-8.
^Briejer, MR; Akkermans, LM; Schuurkes, JA (1995). "Interactions of serotonin with multiple receptors and neurotransmitters in the guinea-pig isolated colon". Archives Internationales de Pharmacodynamie et de Thérapie. 329 (1): 121–33. PMID7639614.
^Burnstock, G; Verkhratsky, A (March 2010). "Vas deferens--a model used to establish sympathetic cotransmission". Trends in Pharmacological Sciences. 31 (3): 131–9. doi:10.1016/j.tips.2009.12.002. PMID20074819.
^Fry, CH (2004). "Experimental models to study the physiology, pathophysiology, and pharmacology of the lower urinary tract". Journal of Pharmacological and Toxicological Methods. 49 (3): 201–10. doi:10.1016/j.vascn.2004.03.002. PMID15172016.
^Dong, Q; Deng, S; Wang, R; Yuan, J (February 2011). "In vitro and in vivo animal models in priapism research". The Journal of Sexual Medicine. 8 (2): 347–59. doi:10.1111/j.1743-6109.2010.02052.x. PMID20946160.
^ abLangton, Philip D. (2012). Essential Guide to Reading Biomedical Papers.
^Vogel, Hans (2008). Drug Discovery and Evaluation: Pharmacological Assays (3 ed.). pp. 9–10. ISBN 978-3-540-70995-4.